ChoiceOne Financial Services reports Q1 2026 results on April 29 with a notable insider buying cluster providing the most distinctive feature of the setup.
The most readable signal heading into earnings is what management has been doing with their own money. Five insiders — including the CFO, the President, and the Independent Chairman — bought shares in February and March at prices between $27.40 and $29.15. The net insider balance over the past 90 days is firmly positive: a combined $705,000 of net buying across 24,350 shares. With the stock now at $30.15, those purchases are modestly in the money, adding a layer of conviction from people with direct access to the Q1 numbers.
Short sellers are not pressing their case. Short interest came in at just 1.3% of the free float — minimal by any measure — and fell roughly 14% in a single session on April 24. Borrow costs have drifted higher over the past month but remain low in absolute terms at 1.9%. Utilization is nearly negligible at under 1%, far below its 52-week high of nearly 17%, which confirms there is no meaningful short-side pressure building into the print. The ORTEX short score of 31 is below the midpoint, consistent with a stock that short sellers are largely ignoring.
The bull case centres on a recovery in valuation and momentum. The stock has climbed 11% over the past month, though it pulled back 2% in the final session before the report. The P/E has expanded alongside that move, now around 8.3x — cheap for the regional bank space. A forward yield near 3.8% provides income support. On the analyst side, DA Davidson raised its target to $34 from $32 just yesterday while maintaining a Buy rating, putting the consensus target modestly above the current price. The bear argument is more structural: Hovde Group downgraded to Market Perform in early January, and earnings-per-share momentum on a 12-month forward basis ranks in the bottom decile, a reminder that earnings growth expectations for the name remain muted. A look at recent earnings reactions suggests the range of outcomes is wide — the October 2025 print produced a 10.8% one-day move to the upside, while the most recent Q1 2026 pre-announcement landed the stock essentially flat. The pattern points to a stock that can reprice sharply, in either direction, on a surprise.
Tuesday's release is therefore less a test of whether the bank is profitable and more a question of whether the net interest margin and loan growth trends justify the multiple expansion of the past month — and whether the insider cohort's late-winter conviction proves well-timed.
See the live data behind this article on ORTEX.
Open COFS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
